ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer

The uncommonness of gallbladder cancer in the developed world has contributed to the generally poor understanding of the disease. Our integrated analysis of whole exome sequencing, copy number alterations, immunohistochemical, and phospho‐proteome array profiling indicates ERBB2 alterations in 40% e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Iyer, Prajish, Shrikhande, Shailesh V., Ranjan, Malika, Joshi, Asim, Gardi, Nilesh, Prasad, Ratnam, Dharavath, Bhasker, Thorat, Rahul, Salunkhe, Sameer, Sahoo, Bikram, Chandrani, Pratik, Kore, Hitesh, Mohanty, Bhabani, Chaudhari, Vikram, Choughule, Anuradha, Kawle, Dhananjay, Chaudhari, Pradip, Ingle, Arvind, Banavali, Shripad, Gera, Poonam, Ramadwar, Mukta R., Prabhash, Kumar, Barreto, Savio George, Dutt, Shilpee, Dutt, Amit
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
Molecular Cancer Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6378102/
https://ncbi.nlm.nih.gov/pubmed/30304546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31916
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados